companydata.dkcompanydata.dk

ZEMA Pharma Consulting ApS: Financial statements 2026

CVR: 42680427

Source: annual report 2026, Danish Business Authority

01/10/2025 – 30/09/2026

ZEMA Pharma Consulting ApS (CVR 42680427) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 73,493 and a net result of DKK -256,741 compared with DKK -216,744 the year before. That is a decrease of 28.1% compared with the year before. Equity in the 2026 report amounted to DKK 97,802. The solvency ratio was 71.7%. The company had 1 employee in the financial year.

Gross Profit
DKK 73,493
Profit/Loss
DKK -256,741
Equity
DKK 97,802
Total Assets
DKK 136,404
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026-73K-257K98K1
2025-102K-217K355K1
2024-131K-282K571K1
2023-1.5M812K853K1
2022-1.1M790K830K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ZEMA Pharma Consulting ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

About ZEMA Pharma Consulting ApS

ZEMA Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Torkild Hansen. The company is owned by Mads Torkild Hansen. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 73,493 and a net result of DKK -256,741 compared with DKK -216,744 the year before. Equity in the 2026 report amounted to DKK 97,802.

Source: annual report 2026, Danish Business Authority

Other financial years